Deutsche Bank analyst George Hill raised the firm’s price target on HealthEquity to $72 from $68 and keeps a Buy rating on the shares. The analyst revised estimates ahead of the consensus following the company’s recent results and investor presentations.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HQY:
- HealthEquity announces HSA sales outlook
- HealthEquity Announces Record HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference
- Sharecare named Top Pick for first half of 2023 at BTIG
- Fly Insider: Willdan Group, Medtronic among weeks’ notable insider transactions
- HealthEquity bullish Fresh Pick designation extended at Baird
